期刊
MOLECULAR PHARMACEUTICS
卷 14, 期 11, 页码 4032-4041出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.7b00704
关键词
acid-activatable; polymeric prodrug; unimolecular micelles; drug delivery; cancer therapy
资金
- Fundamental Research Funds for Central Universities from Southwest University [XDJK2016A010]
- Basic and Frontier Research Project of Chongqing [cstc2016jcyjA0078]
- National Natural Science Foundation of China [51703187, 31671037, 51503172]
- [SWU115058]
- [SWU115059]
Stimuli-responsive nanomedicine with theranostic functionalities with reduced side-effects has attracted growing attention, although there are some major obstacles to overcome before clinical applications. Herein, we present an acid-activatable theranostic unimolecular micelles based on amphiphilic star-like polymeric prodrug to systematically address typical existing issues. This smart polymeric prodrug has a preferable size of about 35 nm and strong micellar stability in aqueous solution, which is beneficial to long-term blood circulation and efficient extravasation from tumoral vessels. Remarkably, the polymeric prodrug has a high drug loading rate up to 53.1 wt%, which induces considerably higher cytotoxicity against tumor cells (HeLa cells and MCF-7 cells) than normal cells (HUVEC cells) suggesting a spontaneous tumor-specific targeting capability. Moreover, the polymeric prodrug can serve as a fluorescent nanoprobe activated by the acidic microenvironment in tumor cells, which can be used as a promising platform for tumor diagnosis. The superior antitumor effect in this in vitro study demonstrates the potential of this prodrug as a promising platform for drug delivery and cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据